Pancreatic Cancer Research

ResearcherYale UniversityNo recent work listed

Joseph W. Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2222-3531; OpenAlex author ID A5068433389. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2016: 1 trial · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 1

  1. Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation. Co-author DOI 10.1002/onco.13758↗

Trials 1

  1. A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors Principal investigator NCT02498613↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ulka N. Vaishampayan · 1 shared paper, 2021 · strength 0.13
  2. Shumei Kato · 1 shared paper, 2021 · strength 0.13
  3. Dana Backlund Cardin · 1 shared paper, 2021 · strength 0.13
  4. Patricia Mucci LoRusso · 1 shared paper, 2021 · strength 0.13
  5. Steven R. Grossman · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.